Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry’s disease. N Engl J Med 1967;276:1163‐7.

Article  CAS  PubMed  Google Scholar 

Frustaci A, Chimenti C, Doheny D, Desnick RJ. Evolution of cardiac pathology in classic Fabry disease: Progressive cardiomyocyte enlargement leads to increased cell death and fibrosis, and correlates with severity of ventricular hypertrophy. Int J Cardiol 2017;248:257‐62.

Article  PubMed  Google Scholar 

Azevedo O, Cordeiro F, Gago MF, Miltenberger-Miltenyi G, Ferreira C, Sousa N. Fabry disease and the heart: A comprehensive review. Int J Mol Sci 2021;22:4434.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehta A, Clarke JTR, Giugliani R, Elliott P, Linhart A, Beck M, et al. Natural course of Fabry disease: Changing pattern of causes of death in FOS-Fabry Outcome Survey. J Med Genet 2009;46:548‐52.

Article  CAS  PubMed  Google Scholar 

Imbriaco M, Pellegrino T, Piscopo V, Petretta M, Ponsiglione A, Nappi C, et al. Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson–Fabry disease. Eur J Nucl Med Mol Imaging 2017;44:2266‐73.

Article  CAS  PubMed  Google Scholar 

Nappi C, Altiero M, Imbriaco M, Nicolai E, Giudice CA, Aiello M, et al. First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson–Fabry disease. Eur J Nucl Med Mol Imaging 2015;42:1025‐31.

Article  CAS  PubMed  Google Scholar 

Spinelli L, Imbriaco M, Giugliano G, Nappi C, Gaudieri V, Riccio E, et al. Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson–Fabry disease. J Nucl Cardiol 2021;28:641‐9.

Article  PubMed  Google Scholar 

Acampa W, D’Antonio A, Imbriaco M, Pisani A, Cuocolo A. Multimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology? J Nucl Cardiol 2020.

Imbriaco M, Nappi C, Ponsiglione A, Pisani A, Dell’Aversana S, Nicolai E, et al. Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson–Fabry disease: AFFINITY study group. Eur Heart J Cardiovasc Imaging 2019;20:1004‐11.

Article  PubMed  Google Scholar 

Nordin S, Kozor R, Vijapurapu R, Augusto JB, Knott KD, Captur G, et al. Myocardial Storage, inflammation, and cardiac phenotype in fabry disease after one year of enzyme replacement. Therapy 2019;12:e009430.

Google Scholar 

Yamamoto S, Suzuki H, Sugimura K, Tatebe S, Aoki T, Miura M, et al. Focal Reduction in cardiac (123)I-metaiodobenzylguanidine uptake in patients with Anderson–Fabry disease. Circ J 2016;80:2550‐1.

Article  PubMed  Google Scholar 

Kalliokoski RJ, Kalliokoski KK, Sundell J, Engblom E, Penttinen M, Kantola I, et al. Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease. J Inherit Metab Dis 2005;28:563‐73.

Article  CAS  PubMed  Google Scholar 

Spinelli L, Pellegrino T, Pisani A, Giudice CA, Riccio E, Imbriaco M, et al. Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by 123I-meta-iodobenzylguanidine imaging in Anderson–Fabry disease. Eur J Nucl Med Mol Imaging 2016;43:729‐39.

Article  CAS  PubMed  Google Scholar 

Luisi AJ, Suzuki G, deKemp R, Haka MS, Toorongian SA, Canty JM, et al. Regional 11C-hydroxyephedrine retention in hibernating myocardium: Chronic inhomogeneity of sympathetic innervation in the absence of infarction. J Nucl Med 2005;46:1368‐74.

CAS  PubMed  Google Scholar 

Massalha S, Slart RHJA. Anderson–Fabry disease: Worthy to in-SPECT the nerves? J Nucl Cardiol 2021;28:650‐2.

Article  PubMed  Google Scholar 

Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B, Captur G, Francois CJ, Jerosch-Herold M, et al. Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson 2020;22:1‐63.

Article  Google Scholar 

Torigian DA, Zaidi H, Kwee TC, Saboury B, Udupa JK, Cho Z-H, et al. PET/MR Imaging: Technical aspects and potential clinical applications. Radiology 2013;267:26‐44.

Article  PubMed  Google Scholar 

Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagi. J Cardiovasc Magn Reson 2017;19:1‐24.

Article  Google Scholar 

Nekolla SG, Miethaner C, Nguyen N, Ziegler SI, Schwaiger M. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med 1998;25:1313‐21.

Article  CAS  PubMed  Google Scholar 

Allman KC, Stevens MJ, Wieland DM, Hutchins GD, Wolfe ER Jr, Greene DA, et al. Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 1993;22:1425‐32.

Article  CAS  PubMed  Google Scholar 

Bengel FM, Ueberfuhr P, Ziegler SI, Nekolla S, Reichart B, Schwaiger M. Serial assessment of sympathetic reinnervation after orthotopic heart transplantation: A longitudinal study using PET and C-11 hydroxyephedrine. Circulation 1999;99:1866‐71.

Article  CAS  PubMed  Google Scholar 

Schwaiger M, Hutchins GD, Kalff V, Rosenspire K, Haka MS, Mallette S, et al. Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest 1991;87:1681‐90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartmann F, Ziegler S, Nekolla S, Hadamitzky M, Seyfarth M, Richardt G, et al. Regional patterns of myocardial sympathetic denervation in dilated cardiomyopathy: An analysis using carbon-11 hydroxyephedrine and positron emission tomography. Int J Cardiol 1999;81:262‐70.

CAS  Google Scholar 

Possner M, Buechel RR, Vontobel J, Mikulicic F, Gräni C, Benz DC, et al. Myocardial blood flow and cardiac sympathetic innervation in young adults late after arterial switch operation for transposition of the great arteries. Int J cardiol 2020;299:110‐5.

Article  PubMed  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604‐12.

Article  PubMed  PubMed Central  Google Scholar 

Linhart A, Elliott PM. The heart in Anderson–Fabry disease and other lysosomal storage disorders. Heart 2007;93:528‐35.

Article  PubMed  PubMed Central  Google Scholar 

Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: A comprehensive review. J Cardiovasc Magn Reson 2016;18:89.

Article  PubMed  PubMed Central  Google Scholar 

Aikawa T, Naya M, Obara M, Oyama-Manabe N, Manabe O, Magota K, et al. Regional interaction between myocardial sympathetic denervation, contractile dysfunction, and fibrosis in heart failure with preserved ejection fraction: (11)C-hydroxyephedrine PET study. Eur J Nucl Med Mol Imaging 2017;44:1897‐905.

Article  CAS  PubMed  Google Scholar 

Fallavollita JA, Heavey BM, Luisi AJ, Michalek SM, Baldwa S, Mashtare TL, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 2014;63:141‐9.

Article  PubMed  Google Scholar 

Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 2012;60:408‐20.

Article  PubMed  PubMed Central  Google Scholar 

Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55:2769‐77.

Article  PubMed  Google Scholar 

Baig S, Edward NC, Kotecha D, Liu B, Nordin S, Kozor R, et al. Ventricular arrhythmia and sudden cardiac death in Fabry disease: A systematic review of risk factors in clinical practice. EP Europace 2018;20:f153‐61.

Article  PubMed  Google Scholar 

Hanneman K, Karur GR, Wasim S, Wald RM, Iwanochko RM, Morel CF. Left ventricular hypertrophy and late gadolinium enhancement at cardiac MRI are associated with adverse cardiac events in Fabry disease. Radiology 2020;294:42‐9.

Article  PubMed  Google Scholar 

Vijapurapu R, Nordin S, Baig S, Liu B, Rosmini S, Augusto J, et al. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease. Heart 2019;105:470‐6.

Article  CAS  PubMed  Google Scholar 

Bengel FM. Imaging of myocardial catecholamine uptake. Circ Cardiovasc Imaging 2018;11:e008534.

Article  PubMed  Google Scholar 

Raffel DM, Jung YW, Koeppe RA, Jang KS, Gu G, Scott PJH, et al. First-in-human studies of [(18)F] fluorohydroxyphenethylguanidines. Circ Cardiovasc Imaging 2018;11:e007965.

Article  PubMed  PubMed Central  Google Scholar 

Werner RA, Rischpler C, Onthank D, Lapa C, Robinson S, Samnick S, et al. Retention kinetics of the 18F-labeled sympathetic nerve PET Tracer LMI1195: Comparison with 11C-hydroxyephedrine and 123I-MIBG. J Nucl Med 2015;56:1429‐33.

Article  CAS  PubMed  Google Scholar 

Coats CJ, Parisi V, Ramos M, Janagarajan K, O’Mahony C, Dawnay A, et al. Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with Anderson–Fabry disease. Heart Ame J Cardiol 2013;111:111‐7.